Live Earnings Conference Call: Mind Medicine (MindMed) will host a live Q1 2025 earnings call on May 8, 2025 at 8:00AM ET. Follow this link to get details and listen to Mind Medicine (MindMed)'s Q1 2025 earnings call when it goes live. Get details. Mind Medicine (MindMed) (MNMD) Insider Trading & Ownership $6.58 +0.27 (+4.20%) Closing price 05/7/2025 03:59 PM EasternExtended Trading$6.50 -0.07 (-1.06%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.26%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$24,085.00Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$749,479.40 Get MNMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Mind Medicine (MindMed) stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MNMD Insider Buying and Selling by Quarter Mind Medicine (MindMed) Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/25/2025Carrie LiaoCAOSell2,347$6.74$15,818.78 3/25/2025Daniel KarlinInsiderSell6,836$6.74$46,074.64 3/25/2025Robert BarrowCEOSell21,208$6.74$142,941.92 12/26/2024Carrie LiaoCAOSell2,273$7.43$16,888.39 12/26/2024Dan KarlinInsiderSell6,643$7.43$49,357.49 12/26/2024Robert BarrowCEOSell19,106$7.43$141,957.58 9/25/2024Carrie LiaoCAOSell2,352$5.98$14,064.96 9/25/2024Dan KarlinInsiderSell6,871$5.98$41,088.58 9/25/2024Robert BarrowCEOSell19,771$5.98$118,230.58 8/23/2024David W GryskaDirectorBuy3,500$5.98$20,930.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/19/2024Robert BarrowCEOBuy500$6.31$3,155.00 6/25/2024Dan KarlinInsiderSell6,925$7.22$49,998.50 6/25/2024Robert BarrowCEOSell15,659$7.22$113,057.98 (Data available from 1/1/2013 forward) MNMD Insider Trading Activity - Frequently Asked Questions Who is on Mind Medicine (MindMed)'s Insider Roster? The list of insiders at Mind Medicine (MindMed) includes Carrie Liao, Dan Karlin, Daniel Karlin, David W Gryska, Robert Barrow, and Schond L Greenway. Learn more on insiders at MNMD. What percentage of Mind Medicine (MindMed) stock is owned by insiders? 2.26% of Mind Medicine (MindMed) stock is owned by insiders. Learn more on MNMD's insider holdings. Which Mind Medicine (MindMed) insiders have been buying company stock? The following insiders have purchased MNMD shares in the last 24 months: David W Gryska ($20,930.00), and Robert Barrow ($3,155.00). How much insider buying is happening at Mind Medicine (MindMed)? Insiders have purchased a total of 4,000 MNMD shares in the last 24 months for a total of $24,085.00 bought. Which Mind Medicine (MindMed) insiders have been selling company stock? The following insiders have sold MNMD shares in the last 24 months: Carrie Liao ($46,772.13), Dan Karlin ($273,928.05), Daniel Karlin ($46,074.64), Robert Barrow ($819,101.69), and Schond L Greenway ($154,376.72). How much insider selling is happening at Mind Medicine (MindMed)? Insiders have sold a total of 238,850 Mind Medicine (MindMed) shares in the last 24 months for a total of $1,340,253.23 sold. Mind Medicine (MindMed) Key ExecutivesMr. Robert Barrow (Age 35)CEO & Director Compensation: $931.13k2 recent tradesDr. Daniel Rollings Karlin M.A. (Age 44)M.D., Chief Medical Officer Compensation: $658.52kDr. Miriam Halperin Wernli B.A. (Age 71)M.A., M.B.A., MBA, Ph.D., Executive President Compensation: $552.46kDr. Scott M. Freeman M.D. (Age 67)Co-Founder & Clinical Advisor Compensation: $319.73kMr. Leonard LatchmanCo-founderMs. Carrie F. Liao CPA (Age 58)CGMA, VP & Chief Accounting Officer 2 recent tradesMr. Mark R. Sullivan J.D. (Age 53)Chief Legal Officer & Corporate Secretary Dr. Francois P. Lilienthal M.B.A.M.D., Chief Commercial OfficerMs. Stephanie FaganChief Corporate Affairs Officer More Insider Trading Tools from MarketBeat Related Companies TARS Insider Trades JANX Insider Trades SDGR Insider Trades ARWR Insider Trades CNTA Insider Trades IDYA Insider Trades ARQT Insider Trades TVTX Insider Trades APGE Insider Trades AGIO Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You? This page (NASDAQ:MNMD) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredNew breed of trader (Wall Street hates us?)Wall Street big wigs and old-money bankers can’t touch this 1 type of stock. And that opens the door for tr...Timothy Sykes | Sponsored270x more lucrative than NVIDIA???270x more lucrative than NVIDIA??? If you've missed out on NVIDIA's recent 1,600% run... Don't worry. ...Behind the Markets | SponsoredTrump’s Secret WeaponALERT: Trump's 2024 Trade War Starts NOW The Dow just nosedived—and it's not a coincidence. Trump's new ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MNMD Stock Free MNMD Stock Alerts